Evolving Paradigms in Triple-Negative Breast Cancer: Treatment
Breast cancer is a leading cause of cancer death in women, with 12% to 20% of cases classified as triple-negative breast cancer.
Evolving Paradigms in Triple-Negative Breast Cancer: References
Evolving Paradigms in Triple-Negative Breast Cancer: Conclusion
The treatment of TNBC continues to be a challenge for physicians because of its limited treatment options, the dearth of approved targeted therapies, high mortality, and poor prognosis.
Evolving Paradigms in Triple-Negative Breast Cancer: Introduction
